Yvanne Enever
A5056295245- SARS-CoV-2 and COVID-19 Research
- Vaccine Coverage and Hesitancy
- Liver Disease Diagnosis and Treatment
- COVID-19 Clinical Research Studies
- Liver Disease and Transplantation
- Ocular Diseases and Behçet’s Syndrome
- Animal Virus Infections Studies
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Immunotherapy and Immune Responses
- Sarcoidosis and Beryllium Toxicity Research
- Bacterial Infections and Vaccines
- Health and Medical Research Impacts
- Paraoxonase enzyme and polymorphisms
- Otitis Media and Relapsing Polychondritis
- Abdominal Trauma and Injuries
- Drug-Induced Adverse Reactions
Dexcel Pharma (United Kingdom)
2024
Hertfordshire Community NHS Trust
2021-2023
University Hospital Southampton NHS Foundation Trust
2023
Churchill Hospital
2023
Some high-income countries have deployed fourth doses of COVID-19 vaccines, but the clinical need, effectiveness, timing, and dose a remain uncertain. We aimed to investigate safety, reactogenicity, immunogenicity fourth-dose boosters against COVID-19.
To evaluate the persistence of immunogenicity three months after third dose boosters.
Developing new treatments that improve outcomes for patients with decompensated cirrhosis remains an unmet area of clinical need. The UK has a rich history being on the forefront trials this patient group. However, there have been challenges in achieving goal past decade, several negative studies as well struggling to achieve recruitment. This further exacerbated by changed landscape following COVID-19 pandemic. In response this, O’Shaughnessy report was commissioned identify potential...
Liver disease is a major, and increasing, cause of death in the UK. The UK Chronic Failure network (UK-CLIF) was developed as multi-stakeholder with aim to advance cirrhosis research, emphasis on geographical areas high prevalence or limited research activity. process involved development through dissemination snowball sampling techniques, monitoring connections between participants, over two online meetings. Network membership included representatives from patients, carers, clinicians,...